Cargando…

Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in elderly people. Currently, the diagnosis of PD is based on neurological examination, neuroimaging, and the response to dopaminergic medication. The diagnosis can be challenging, especially at early disease stages, when...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Tainá M., van Rumund, Anouke, Bruinsma, Ilona B., Wessels, Hans J. C. T., Gloerich, Jolein, Esselink, Rianne A. J., Bloem, Bastiaan R., Kuiperij, H. Bea, Verbeek, Marcel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647396/ https://www.ncbi.nlm.nih.gov/pubmed/30465235 http://dx.doi.org/10.1007/s12035-018-1426-9

Ejemplares similares

Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
por: Marques, Tainá M., et al.
Publicado: (2021)

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System Atrophy
por: Marques, Tainá M., et al.
Publicado: (2016)

Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson’s disease
por: Santaella, Anna, et al.
Publicado: (2020)

Inflammation biomarker discovery in Parkinson’s disease and atypical parkinsonisms
por: Santaella, Anna, et al.
Publicado: (2020)

α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2019)

Factors associated with mortality in early stages of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2022)

Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism
por: van Rumund, Anouke, et al.
Publicado: (2018)

Proteomic profiling of striatal tissue of a rat model of Parkinson's disease after implantation of collagen‐encapsulated human umbilical cord mesenchymal stem cells
por: Santaella, Anna, et al.
Publicado: (2020)

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
por: Herbert, Megan K., et al.
Publicado: (2015)

Conventional 3T brain MRI and diffusion tensor imaging in the diagnostic workup of early stage parkinsonism
por: Meijer, Frederick J. A., et al.
Publicado: (2015)

Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson’s Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study
por: Meijer, Frederick J.A., et al.
Publicado: (2016)

Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
por: van Rumund, Anouke, et al.
Publicado: (2021)

MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
por: Müller, Mareike, et al.
Publicado: (2015)

Trait Impulsivity Is Associated with the Risk of Falls in Parkinson’s Disease
por: Smulders, Katrijn, et al.
Publicado: (2014)

Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism
por: Meijer, Frederick J.A., et al.
Publicado: (2017)

Mechanisms of peripheral levodopa resistance in Parkinson’s disease
por: Beckers, Milan, et al.
Publicado: (2022)

Assessment of dual tasking has no clinical value for fall prediction in Parkinson’s disease
por: Smulders, Katrijn, et al.
Publicado: (2012)

Translating Evidence to Advanced Parkinson's Disease Patients: A Systematic Review and Meta‐Analysis
por: Nijhuis, Frouke A.P., et al.
Publicado: (2021)

Gender Distribution in Deep Brain Stimulation for Parkinson’s Disease: The Effect of Awake versus Asleep Surgery
por: Vinke, R. Saman, et al.
Publicado: (2022)

A multifunctional ELISA to measure oxidised proteins: oxPin1 in Alzheimer's brain as an example
por: Herbert, Megan K., et al.
Publicado: (2015)

The Role of Microelectrode Recording in Deep Brain Stimulation Surgery for Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Vinke, R. Saman, et al.
Publicado: (2022)

Contribution of routine brain MRI to the differential diagnosis of parkinsonism: a 3-year prospective follow-up study
por: Meijer, Frederick J. A., et al.
Publicado: (2011)

Pulsatile Proptosis due to Intraorbital Meningocele
por: van Rumund, Anouke, et al.
Publicado: (2017)

A LRSAM1 mutation links Charcot–Marie–Tooth type 2 to Parkinson's disease
por: Aerts, Marjolein B., et al.
Publicado: (2015)

Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease
por: De Kort, Anna M., et al.
Publicado: (2021)

Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: van den Berg, Emma, et al.
Publicado: (2023)

Reduced Influence of apoE on Aβ43 Aggregation and Reduced Vascular Aβ43 Toxicity as Compared with Aβ40 and Aβ42
por: Jäkel, Lieke, et al.
Publicado: (2020)

Inhibition of Neuroinflammation May Mediate the Disease-Modifying Effects of Exercise: Implications for Parkinson’s Disease
por: Darweesh, Sirwan K.L., et al.
Publicado: (2022)

Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Whole Cell Formaldehyde Cross-Linking Simplifies Purification of Mitochondrial Nucleoids and Associated Proteins Involved in Mitochondrial Gene Expression
por: Rajala, Nina, et al.
Publicado: (2015)

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood‐brain barrier
por: Biemans, Elisanne A.L.M., et al.
Publicado: (2016)

The Role of Microelectrode Recording and Stereotactic Computed Tomography in Verifying Lead Placement During Awake MRI-Guided Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease
por: Vinke, R. Saman, et al.
Publicado: (2022)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy
por: Vervuurt, Marc, et al.
Publicado: (2023)

Enhanced motivation of cognitive control in Parkinson's disease
por: Timmer, Monique H.M., et al.
Publicado: (2018)

People with Parkinson’s as Partners for the Journal of Parkinson’s Disease
por: McFarthing, Kevin, et al.
Publicado: (2023)

Biphasic Levodopa-Induced Freezing of Gait in Parkinson’s Disease
por: Nonnekes, Jorik, et al.
Publicado: (2020)

The Journal of Parkinson’s Disease Takes the Open Road
por: Bloem, Bastiaan R., et al.
Publicado: (2023)

The Times They Are a-Changin’: Parkinson’s Disease 20 Years from Now
por: Brundin, Patrik, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cpluelkdqsglug0g2u0ildafrl